Expect more soreness
A practical estimate is 5 to 10 percent loss, so reduce these numbers accordingly
Lilly recently reported topline results from the ATTAIN-1 phase-3 trial evaluating orforglipron, a once-daily oral glucagon-like-peptide-1 (GLP-1) receptor agonist for adults with obesity or overweight without diabetes
10.3390/antiox14091033 38 GuerraC.MorrisD.SipinA.KungS.FranklinM.GrayD.et al (2011)
*These findings show an association between stopping GLP-1 RAs and these outcomes, but not a causation
But the question on many peoples minds when it comes to drugs like Wegovy or Zepbound is: Can I afford it? (Well, maybe after, How quickly can I get it?) The cost of brand-name injectable weight loss drugs ranges from $25 to $1,400 per month , depending on the medication, pharmacy used, and insurance coverage